BioHealth News Archive
Digital Health Flexes Muscle at Vaunted Biotech Conference – Venture Capital Dispatch – WSJ
The Colonial Room of the St. Francis Hotel in San Francisco was filled beyond capacity Monday afternoon, and the offices of digital-health seed fund Rock…
Read MoreRoche says licenses EGFR pathway-related intellectual property to QIAGEN – Reuters
Swiss drugmaker Roche said on Wednesday it had entered into an agreement with QIAGEN that includes a provision of non-exclusive licenses to recently granted…
Read MoreFirst flexing human muscle grown in lab – ScienceBlog.com
In a laboratory first, Duke researchers have grown human skeletal muscle that contracts and responds just like native tissue to external stimuli such as…
Read MoreWhat will Mike Gill have to do to be successful at DBED? – Baltimore Business Journal
It didn't take R. Michael Gill very long to come up with some priorities after Gov.-elect Larry Hogan named him the next Maryland Department…
Read MoreLockheed Martin’s getting personal with its latest health partnership – Washington Business Journal
Lockheed Martin Corp. is normally known for big things – tanks, planes, ships, those kinds of projects. But a new partnership the defense giant…
Read MoreAccelerateBaltimore 2015 Companies Announced
The ETC (Emerging Technology Centers) www.etcbaltimore.com, Baltimore City’s award-winning technology innovation centers, announced today that the following six companies have been accepted into the…
Read MoreDC Inno Beat 1/13: VC Fundraising- Where’s the Money, More Coworking- Too much? – DC Inno
Show me the money, I'm not seeing it here. According to NVCA, U.S. VC firms raised $29.8B in 2014, making it the best fundraising year since 2007…
Read MoreAstraZeneca plc: MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Omnis Pharmaceuticals (Omnis), a privately-held…
Read MoreAngel investor tax credit could make Maryland more appealing to investors, entrepreneurs – Baltimore Business Journal
Washington, D.C., Philadelphia, New York — Maryland has a lot of competition for entrepreneurs' attention. Experts say a tax credit specifically for angel investors…
Read MoreQiagen (QGEN) Launches Next-Gen TB Infection Test – Zacks.com
Sample and assay technologies provider Qiagen NV recently announced the launch of its latest diagnostic TB test– QuantiFERON-TB Gold-Plus (QFT-Plus), subsequent to the product’s…
Read MoreAlexandria Real Estate seeking to raise $20 million to back digital health in S.F. – The Technology Chronicles
Alexandria Real Estate Equities, the real estate firm that helped transform Mission Bay into a thriving life-science hub, now wants to raise up to…
Read MoreHuman genome pioneer J. Craig Venter taps Baltimore startup for next project – Baltimore Business Journal
J. Craig Venter was one of the first scientists in 2001 to map the human genome. Now this trailblazer in genome sequencing research has…
Read MoreBD Intelliport IV Medication Management System Cleared by FDA (VIDEO)
BD Medical, a part of Becton, Dickinson and Company, announced receiving FDA clearance for its Intelliport Medication Management System. The product monitors manual IV bolus…
Read MoreQualcomm and Novartis Part 2: Let’s start an investment company
The Beyond the Pill movement took an interesting turn this week when Qualcomm announced plans to open an investment business with Novartis, according to…
Read MoreAstraZeneca – MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Omnis Pharmaceuticals (Omnis), a privately-held…
Read More